stockrowEmergent Biosolutions Inc. (EBS) vs Lifecore Biomedical, Inc. (LFCR)
- Emergent Biosolutions Inc. EBS 6.01 +2.74%
- Lifecore Biomedical, Inc. LFCR 6.37 −0.47%
Emergent Biosolutions Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $300.8M against $242.6M — 1.2× the size. Emergent Biosolutions Inc. grew revenue faster over the last twelve months: −17.7% against −18.2%. Emergent Biosolutions Inc. has the higher net margin (−40.2% vs −65.9%) and the lower return on invested capital (−17.5% vs 0.00%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 11 and Lifecore Biomedical, Inc. on 8.
Valuation
Profitability
| Metric | EBS | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 48.42% | 27.38% | 53.51% |
| Operating margin | (27.70%) | (5.33%) | 0.00% |
| Net margin | (40.16%) | (65.91%) | (2.45%) |
| Free cash flow margin | 29.89% | 9.86% | 0.00% |
| Return on equity | (58.21%) | 178.69% | (0.80%) |
| Return on assets | (21.23%) | (32.36%) | (1.67%) |
| Return on invested capital | (17.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack